Empagliflozin Effects in Patients with ST-Elevation Myocardial Infarction Undergoing Primary PCI: The EMI-STEMI Randomized Clinical Trial.
Elnaz KhaniNaser AslanabadiKazem MehravaniHaleh RezaeiHoda AfshariradTaher Entezari-MalekiPublished in: American journal of cardiovascular drugs : drugs, devices, and other interventions (2024)
Iranian Registry of Clinical Trials Platform ( https://irct.behdasht.gov.ir/ ) identifier number IRCT20111206008307N42.
Keyphrases
- st elevation myocardial infarction
- percutaneous coronary intervention
- clinical trial
- st segment elevation myocardial infarction
- coronary artery disease
- acute myocardial infarction
- acute coronary syndrome
- antiplatelet therapy
- coronary artery bypass grafting
- double blind
- randomized controlled trial
- atrial fibrillation
- study protocol
- phase iii
- left ventricular